Safety and efficacy of zilucoplan in patients with generalised myasthenia gravis (RAISE): a randomised, double-blind, placebo-controlled, phase 3 study.
The Lancet. Neurology（2023）
摘要
UCB Pharma.
更多查看译文
关键词
myasthenia gravis,generalised myasthenia gravis,zilucoplan,double-blind,placebo-controlled
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要